Functional Magnetic Nanoparticle Assemblies: Formation, Collective Behavior, and Future Directions

ACS Nano ◽  
2011 ◽  
Vol 5 (8) ◽  
pp. 6081-6084 ◽  
Author(s):  
S. A. Majetich ◽  
T. Wen ◽  
R. A. Booth
ACS Sensors ◽  
2018 ◽  
Vol 3 (9) ◽  
pp. 1884-1891 ◽  
Author(s):  
Bo Tian ◽  
Yuanyuan Han ◽  
Erik Wetterskog ◽  
Marco Donolato ◽  
Mikkel Fougt Hansen ◽  
...  

2015 ◽  
Vol 3 (11) ◽  
pp. 2241-2276 ◽  
Author(s):  
Erwin Peng ◽  
Fenghe Wang ◽  
Jun Min Xue

The development of water-soluble nanostructured magnetic nanocomposites based on hydrophobic magnetic nanoparticle assemblies using an organic functional coating for MRI contrast agent applications was discussed.


2003 ◽  
Vol 93 (10) ◽  
pp. 7343-7345 ◽  
Author(s):  
S. Anders ◽  
M. F. Toney ◽  
T. Thomson ◽  
J.-U. Thiele ◽  
B. D. Terris ◽  
...  

2018 ◽  
Vol 98 (5) ◽  
Author(s):  
Alexander Fabian ◽  
Michael Czerner ◽  
Christian Heiliger ◽  
Matthias T. Elm ◽  
Detlev M. Hofmann ◽  
...  

Nanomedicine ◽  
2022 ◽  
Author(s):  
Dhruba Dhar ◽  
Swachhatoa Ghosh ◽  
Soumen Das ◽  
Jyotirmoy Chatterjee

Rapid vascular growth, infiltrative cells and high tumor heterogenicity are some glioblastoma multiforme (GBM) characteristics, making it the most lethal form of brain cancer. Low efficacy of the conventional treatment modalities leads to rampant disease progression and a median survival of 15 months. Magnetic nanoparticles (MNPs), due to their unique physical features/inherent abilities, have emerged as a suitable theranostic platform for targeted GBM treatment. Thus, new strategies are being designed to enhance the efficiency of existing therapeutic techniques such as chemotherapy, radiotherapy, and so on, using MNPs. Herein, the limitations of the current therapeutic strategies, the role of MNPs in mitigating those inadequacies, recent advances in the MNP-based theranostics of GBM and possible future directions are discussed.


Sign in / Sign up

Export Citation Format

Share Document